You are viewing an incomplete version of our website. Please click to reload the website as full version.

Wilms Tumor 1 (WT1) (AA 349-439) antibody

Details for Product No. ABIN394194, Supplier: Login to see New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Synonyms WT1, WT, XWT1a, wt-1, wt1, xWT1, gud, wagr, wt33, xwt1, wit-2, AWT1, EWS-WT1, GUD, NPHS4, WAGR, WIT-2, WT33, XWT1b, XeWT1, CWT1, WT-1, D630046I19Rik, Wt-1, si:ch211-160j6.3, zgc:152697
AA 349-439
(22), (22), (16), (14), (11), (10), (9), (9), (9), (5), (4), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1)
(140), (35), (32), (2), (1), (1), (1), (1), (1)
(75), (49), (16)
Clonality (Clone)
Monoclonal ()
(5), (5), (4), (3), (3), (3), (1), (1), (1), (1)
Western Blotting (WB)
(94), (49), (47), (43), (39), (26), (21), (5), (5), (2), (1), (1), (1), (1)
Pubmed 5 references available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 0.1 mg
Shipping to United States ( )
Availability Will be delivered in 8 to 11 Business Days
Immunogen WT1 (NP_000369, 349 a.a. ~ 439 a.a) full length recombinant protein with GST tag. MW of the GST tag alone is 26 K
Clone 2H4
Isotype IgG2b kappa
Specificity WT1 (NP_000369, 349 a.a. ~ 439 a.a) full length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Purification This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
Alternative Name WT1 (WT1 Antibody Abstract)
Background Synonyms: Serine protease inhibitor J6, 47 kDa heat shock protein, Collagen-binding protein, Colligin, Serpin H1,Hsp47, Cbp1, Serpinh1
Molecular Weight 49188 DA
Gene ID 12406
NCBI Accession NP_000369
Research Area Translation Factors, Cancer, Transcription Factors, Signaling, Cell Structure
Application Notes Western blot = 1:500-1000

Background: This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilm's tumors. Multiple transcript variants, resulting from alternative splicing at two coding exons, have been well characterized. There is also evidence for the use of non-AUG (CUG) translation initiation site upstream of, and in-frame with the first AUG, leading to additional isoforms. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated.

Restrictions For Research Use only
Buffer PBS with 0.09% (w/v) sodium azide.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C/-20 °C
Storage Comment Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Expiry Date 6 months
Supplier Images
Western Blotting (WB) image for anti-Wilms Tumor 1 (WT1) (AA 349-439) antibody (ABIN394194) WT1 monoclonal antibody (M01), clone 2H4 Western Blot analysis of WT1 expression in A...
Background publications Rocquain, Carbuccia, Trouplin et al.: "Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias." in: BMC cancer, Vol. 10, pp. 401, 2010 (PubMed).

Hollink, van den Heuvel-Eibrink, Zimmermann et al.: "No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemia." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 28, Issue 28, pp. e523-6; author reply e527-e528, 2010 (PubMed).

Borbulevych, Do, Baker: "Structures of native and affinity-enhanced WT1 epitopes bound to HLA-A*0201: implications for WT1-based cancer therapeutics." in: Molecular immunology, Vol. 47, Issue 15, pp. 2519-24, 2010 (PubMed).

Bachas, Schuurhuis, Hollink et al.: "High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine." in: Blood, Vol. 116, Issue 15, pp. 2752-8, 2010 (PubMed).

Machuca, Benoit, Nevo et al.: "Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome." in: Journal of the American Society of Nephrology : JASN, Vol. 21, Issue 7, pp. 1209-17, 2010 (PubMed).

Catalog No. ABIN394194
Plus shipping costs $45.00

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)